FDC
Back to Balance Sheet
|
FDC Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹108 Cr | ₹74 Cr | ₹60 Cr | ₹56 Cr | ₹38 Cr |
What is the latest Contingent Liabilities ratio of FDC ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹108 Cr |
| Mar2024 | ₹74 Cr |
| Mar2023 | ₹60 Cr |
| Mar2022 | ₹56 Cr |
| Mar2021 | ₹38 Cr |
How is Contingent Liabilities of FDC Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹108 Cr | 44.57 | |
| Mar2024 | ₹74 Cr | 24.95 | |
| Mar2023 | ₹60 Cr | 5.77 | |
| Mar2022 | ₹56 Cr | 48.30 | |
| Mar2021 | ₹38 Cr | - | |
Compare Contingent Liabilities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹5,578.3 Cr | 1.9% | -7.4% | -25.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | 1.9% |
-7.4% |
-25.2% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses